Luc Sensebé - Concepedia

Author

Luc Sensebé

Inserm

Also Known As

L Sensebe, L Sensebé, L Sensèbe, L Sensébé, L. Sensebe, L. Sensebè, L. Sensebé, L. Sensèbe, L. Sensébé, LUC SENSEBE

190

Publications

12.5K

Citations

H-Index

115

Concepts

All Affiliations

Inserm Établissement Français du Sang Centre National de la Recherche Scientifique Université Toulouse III - Paul Sabatier Université de Tours

About

Luc Sensebé is an author at Inserm specializing in medicine, regenerative medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	39	4.8K
2	Biomedical Engineering	15	17	1.1K
3	Engineering	12	14	844
4	Health Sciences	7	7	729
5	Management	1	1	18

Luc Sensebé

Publications

8.3K

Citations

H-Index

Page 1

	Year	Citations
Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature Sowmya Viswanathan, Yufang Shi, Jacques Galipeau, Cytotherapy Regenerative MedicineCell TherapyDevelopmental BiologyInternational SocietyMedicine	2019	777
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials Jacques Galipeau, Mauro Krampera, John Barrett, Cytotherapy Cell TherapyInternational SocietyMedicineImmunologyCellular Therapy Perspective	2015	491
Adipose Mesenchymal Stromal Cell-Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose-Escalation Trial Yves‐Marie Pers, Lars Rackwitz, Rosanna Ferreira, Stem Cells Translational Medicine	2016	482
Immunological characterization of multipotent mesenchymal stromal cells—The International Society for Cellular Therapy (ISCT) working proposal Mauro Krampera, Jacques Galipeau, Yufang Shi, Cytotherapy Regenerative MedicineCells—the International SocietyCell TherapyMedicineImmunology	2013	458
Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation Karin Tarte, Julien Burlaud‐Gaillard, Jean‐Jacques Lataillade, Blood	2009	422
Defining the risks of mesenchymal stromal cell therapy Darwin J. Prockop, Malcolm K. Brenner, Willem E. Fibbe, Cytotherapy Regenerative MedicineTranslational MedicineCell TherapyCellular TherapiesMedicine	2010	348
Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components Natalie Fekete, Mélanie Gadelorge, Daniel E. Fürst, Cytotherapy Regenerative MedicineApheresis-derived Platelet ConcentratesThrombopoiesisActive ComponentsEngineering	2012	282
Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells Bruno Delorme, Jochen Ringe, Nathalie Gallay, Blood	2007	265
The Human Nose Harbors a Niche of Olfactory Ectomesenchymal Stem Cells Displaying Neurogenic and Osteogenic Properties Bruno Delorme, Emmanuel Nivet, Julien Burlaud‐Gaillard, Stem Cells and Development Adult Stem CellRegenerative MedicineOsteogenic PropertiesStem CellsCell Transplantation	2009	251
Identification of IL-10 and TGF-β Transcripts Involved in the Inhibition of T-Lymphocyte Proliferation During Cell Contact With Human Mesenchymal Stem Cells Aisha Nasef, Alain Chapel, Christelle Mazurier, Gene Expression Regenerative MedicineMesenchymal Stem CellsCell TherapyLymphocyte DevelopmentMedicine	2006	223

Page 1